期刊
CELL AND BIOSCIENCE
卷 13, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s13578-023-01063-x
关键词
Angiotensin II type 1 receptor; Conformation; Allostery; Biased ligands; Dimers; Allosteric pocket
Angiotensin II type 1 receptor (AT1R) is a promising therapeutic target for cardiovascular diseases. However, there have been no clinical trials on allosteric modulators of AT1R. This review summarizes the different allosteric modes of AT1R and discusses the future of drug design targeting AT1R allostery.
Angiotensin II type 1 receptor (AT1R) is a promising therapeutic target for cardiovascular diseases. Compared with orthosteric ligands, allosteric modulators attract considerable attention for drug development due to their unique advantages of high selectivity and safety. However, no allosteric modulators of AT1R have been applied in clinical trials up to now. Except for the classical allosteric modulators of AT1R such as antibody, peptides and amino acids, cholesterol and biased allosteric modulators, there are non-classical allosteric modes including the ligand-independent allosteric mode, and allosteric mode of biased agonists and dimers. In addition, finding the allosteric pockets based on AT1R conformational change and interaction interface of dimers are the future of drug design. In this review, we summarize the different allosteric mode of AT1R, with a view to contribute to the development and utilization of drugs targeting AT1R allostery.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据